申请人:ARK Diagnostics, Inc.
公开号:US11231424B2
公开(公告)日:2022-01-25
Methods, compositions and kits are disclosed directed at levetiracetam derivatives, immunogens, signal generating moieties, antibodies that bind levetiracetam and immunoassays for detection of levetiracetam.
已公开的方法、组合物和试剂盒涉及左乙拉西坦衍生物、免疫原、信号产生分子、结合左乙拉西坦的抗体以及检测左乙拉西坦的免疫测定。